Jinhe Biotechnology CO., LTD. (SHE:002688)

China flag China · Delayed Price · Currency is CNY
6.12
+0.03 (0.49%)
At close: Mar 10, 2026
39.09%
Market Cap 4.60B
Revenue (ttm) 2.75B
Net Income (ttm) 125.51M
Shares Out 752.11M
EPS (ttm) 0.16
PE Ratio 37.49
Forward PE 25.50
Dividend 0.10 (1.64%)
Ex-Dividend Date Jun 6, 2025
Volume 7,448,615
Average Volume 11,722,262
Open 6.11
Previous Close 6.09
Day's Range 6.09 - 6.14
52-Week Range 4.39 - 8.69
Beta 0.48
RSI 46.19
Earnings Date Apr 29, 2026

About SHE:002688

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China and internationally. It offers chlortetracycline premixes; veterinary drug and powder series; disinfectants; and sprinklers. It also engages in the production and sales of feed and raw materials. The company was founded in 1990 and is headquartered in Hohhot, China. [Read more]

Sector Healthcare
Founded 1990
Employees 2,476
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002688
Full Company Profile

Financial Performance

In 2024, SHE:002688's revenue was 2.37 billion, an increase of 9.04% compared to the previous year's 2.17 billion. Earnings were 100.20 million, an increase of 15.90%.

Financial Statements

News

There is no news available yet.